January 2020

GASTROENTEROLOGY

OPTIMIZING BIOLOGIC AND CONVENTIONAL THERAPIES FOR INFLAMMATORY BOWEL DISEASE

Featuring: Stephen B. Hanauer, MD

Episode Summary

In this episode of the Better Edge podcast, ​Stephen B. Hanauer, MD, a world-renowned expert in IBD, discusses the latest advances in IBD treatment, including the evolving role of conventional therapy and expanding the role of biologic therapy. Dr. Hanauer also shares his research on the efficacy of adalimumab and study of higher versus standard adalimumab dosing regimens in patients with moderate to severely active ulcerative colitis. 
Stephen B. Hanauer, MD, Clifford Joseph Barborka Professor and professor of medicine in the Division of Gastroenterology and Hepatology at Northwestern Medicine. 

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like